ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 241 filers reported holding ARRAY BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $17,203,000 | +2382.4% | 371,306 | +798.8% | 0.49% | +1941.7% |
| Q2 2018 | $693,000 | -44.3% | 41,310 | -45.9% | 0.02% | -40.0% |
| Q1 2018 | $1,245,000 | +659.1% | 76,307 | +494.6% | 0.04% | +900.0% |
| Q4 2017 | $164,000 | -82.3% | 12,834 | -82.9% | 0.00% | -83.3% |
| Q3 2017 | $925,000 | +50.7% | 75,184 | +2.5% | 0.02% | +26.3% |
| Q2 2017 | $614,000 | -32.6% | 73,373 | -45.6% | 0.02% | -9.5% |
| Q3 2016 | $911,000 | +101.1% | 135,000 | +25.8% | 0.02% | +61.5% |
| Q4 2015 | $453,000 | +771.2% | 107,347 | +833.5% | 0.01% | +550.0% |
| Q3 2015 | $52,000 | – | 11,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |